数智赋能筑根基，鲁抗医药荣获第七届“济宁市市长质量奖”

Core Viewpoint - Shandong Lukang Pharmaceutical Co., Ltd. is enhancing its automation, intelligence, and digitalization to meet market demands, establishing a competitive advantage through a comprehensive quality management model called "Three Quality Linkage" [1][3] Group 1: Production and Demand - The production of the third-generation cephalosporin, Cefotaxime, has seen a 50% increase in orders compared to the same period last year, with orders extending to March [2] - The 102 production workshop has increased its daily output by 20% compared to the same period last year, ensuring timely fulfillment of market orders [2] - The introduction of a fully automated online weighing and magnetic suspension filling machine has improved production capacity by 40% and reduced labor by 40% [2] Group 2: Quality Management - The "Three Quality Linkage" model integrates quality management across research, production, and sales, enhancing service capabilities [3] - The company has achieved a 100% first-pass and market inspection pass rate over the past five years, with over 110,000 batches produced and more than 3,000 batches inspected [3] - The company has received multiple accolades for its quality management, including the recent "Jining Mayor Quality Award" [3][4] Group 3: Future Plans - The company aims to continue high-standard quality management and drive quality upgrades through technological innovation and process improvements [4] - Future initiatives will focus on integrating green production with quality enhancement to achieve economic, social, and ecological benefits [4]